Simone Krebs, MD, MS
Nuclear Medicine Physician & Physician-Scientist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- PET/CT
- General Diagnostic and Therapeutic Nuclear Medicine
About Me
- Assistant Attending Radiologist
I am an American Board of Nuclear Medicine–certified physician-scientist trained in molecular imaging and targeted radiotherapy. I have extensive experience in nuclear medicine and frequently work with colleagues across departments at Memorial Sloan Kettering Cancer Center to take an interdisciplinary approach to disease management.
Read more
My research leverages my training in translational and clinical research and currently focuses on tracking adoptively transferred cells and evaluating theranostic approaches (imaging combined with targeted therapy) for neuroendocrine and brain tumors, and for other cancers. Through my research, I hope to contribute to the exciting field of radiotheranostics, with a focus on T cell therapy, which is starting to show its great potential to improve outcomes for people with cancer.
A nuclear medicine physician is a doctor with special training in using radioactive drugs to diagnose and treat disease.
A physician-scientist is a doctor who also is a researcher.
My Specialties
- PET/CT
- General Diagnostic and Therapeutic Nuclear Medicine
Education
- MD, Albert-Ludwigs-University, Freiburg, Germany
- MS, Clinical and Translational Sciences, Weill Cornell Graduate School of Medical Sciences, New York, NY
Residencies
- Nuclear Medicine - University of Freiburg, Germany
- Molecular Imaging and Therapy - Memorial Sloan Kettering Cancer Center
Awards and Honors
- Saul Hertz Young Investigator Award, 7th Theranostics World Congress (2024)
- NIH R37 (MERIT) Award (2021)
- SNMMI “One to Watch”
- Annual list of 30 early career professionals selected by Society of Nuclear Medicine and Molecular Imaging (SNMMI) (2021)
- EANM Springer Prize 2020 - EJNMMI Best Paper (“Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors”) (2020)
- NIH SPORE Lymphoma Career Enhancement Program Award (2020)
- Larry E. Kun, MD Award of Academic Excellence and Dedication to Cures (2018
- Advanced Certificate in Clinical & Translational Investigation (Weill Cornell Graduate School) (2016)
- NIH K12 Paul Calabresi Career Development Award for Clinical Oncology (2016)
- Best Poster – Travel Grant for “First in-Human Trial of Dasatinib-Tracer PET Imaging: Preliminary Results in Cancer Patients” at the ACNM Annual Meeting and SNMMI Mid-Winter Meeting San Antonio, TX, January 22, 2015 (2015)
Fellowships
- Molecular Imaging and Therapy - Memorial Sloan Kettering Cancer Center
Board Certifications
- Nuclear Medicine
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Contact and Location
Dr. Krebs sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Co-Investigated by Dr. Krebs
- A Phase I Study of 177Lu-DOTA-EB-TATE in People with Advanced Neuroendocrine Cancers
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Krebs’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Simone Krebs discloses the following relationships and financial interests:
-
Telix Pharmaceuticals Limited
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].